Grant: Canada Postdoctoral Research Award (CPRA) program
Direct Payment
$140,000.00
Proteogenomic Analysis of Human Glymphatic Function to Identify Therapeutic Targets for Stroke and Dementia
FY 2025-26
Summary
Brain injury due to damage to the brain's small blood vessels - known as small vessel disease - is common as people get older and often leads to devastating consequences such as stroke and dementia. There are still no effective treatments to directly target the causes of small vessel disease, partly because it remains poorly understood. A recently discovered network of fluid-filled spaces around the brain's blood vessels - known as the 'glymphatic system' - plays a pivotal role in clearing waste from the brain. When this system does not function properly, harmful waste may build up and contribute to small vessel disease. However, the reasons why the glymphatic system fails remain poorly understood. Unlocking these causes could open new opportunities to prevent small vessel disease at its earliest stages and, in turn, reduce the burden of stroke and dementia. For this reason, we aim to identify the drivers of glymphatic system dysfunction and their links with small vessel disease using two powerful instruments (common variations in genes and blood proteins) in three established cohorts in France, Germany and the UK that include advanced brain imaging. First, we will study common genetic variants in these participants to see how they affect specific genes and potentially disrupt the glymphatic system. Next, we will analyze thousands of proteins in their blood to understand how changes in protein levels may contribute to glymphatic system malfunction. Finally, we will identify the drivers of glymphatic system impairment and determine how they lead to small vessel disease by comparing common genetic variations affecting both processes. In summary, we will use cutting-edge brain imaging to determine the link between glymphatic system failure and small vessel disease, understand the causes of small vessel disease and identify potential treatments for stroke and dementia.
Department
Program
Canada Postdoctoral Research Award (CPRA) program
Recipient
Location
France
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
536913
Name
Rioux Bastien
Country
France
Orgtype
Research Institution
Instname2
Circulatory and Respiratory Health
Theme2
Clinical
Prcname2
Canada Postdoctoral Research Award - A
Projecttitle
Proteogenomic Analysis of Human Glymphatic Function to Identify Therapeutic Targets for Stroke and Dementia
Programtype2
Fellowship Programs
Orgnameinp2
Direct Payment
Cihramount2
$140,000
Cihrequipment2
$0
Programname2
Canada Postdoctoral Research Award (CPRA) program
Keyworddelim
Dementia; Diffusion Magnetic Resonance Imaging; Drug Targets; Genetic Association Studies; Glymphatic System; Large Biobanks; Proteomic Profiling; Resting State Functional Magnetic Resonance Imaging; Small Vessel Disease; Stroke
Abstract
Brain injury due to damage to the brain's small blood vessels - known as small vessel disease - is common as people get older and often leads to devastating consequences such as stroke and dementia. There are still no effective treatments to directly target the causes of small vessel disease, partly because it remains poorly understood. A recently discovered network of fluid-filled spaces around the brain's blood vessels - known as the 'glymphatic system' - plays a pivotal role in clearing waste from the brain. When this system does not function properly, harmful waste may build up and contribute to small vessel disease. However, the reasons why the glymphatic system fails remain poorly understood. Unlocking these causes could open new opportunities to prevent small vessel disease at its earliest stages and, in turn, reduce the burden of stroke and dementia. For this reason, we aim to identify the drivers of glymphatic system dysfunction and their links with small vessel disease using two powerful instruments (common variations in genes and blood proteins) in three established cohorts in France, Germany and the UK that include advanced brain imaging. First, we will study common genetic variants in these participants to see how they affect specific genes and potentially disrupt the glymphatic system. Next, we will analyze thousands of proteins in their blood to understand how changes in protein levels may contribute to glymphatic system malfunction. Finally, we will identify the drivers of glymphatic system impairment and determine how they lead to small vessel disease by comparing common genetic variations affecting both processes. In summary, we will use cutting-edge brain imaging to determine the link between glymphatic system failure and small vessel disease, understand the causes of small vessel disease and identify potential treatments for stroke and dementia.
Competitiondate
202509
Approvedterm2
2 yrs 0 mth
Pinamesdelim
Rioux, Bastien
Approvedterm
2 ans 0 mois
Cihrcontribution2
~ $140,000~ $0~